Surgery Partners (NASDAQ:SGRY) Stock Price Down 5.6%

Surgery Partners Inc (NASDAQ:SGRY) traded down 5.6% on Wednesday . The stock traded as low as $16.81 and last traded at $16.89, 660,252 shares changed hands during mid-day trading. An increase of 64% from the average session volume of 403,575 shares. The stock had previously closed at $17.89.

Several equities analysts have weighed in on the company. ValuEngine downgraded Surgery Partners from a “buy” rating to a “hold” rating in a research report on Friday, January 3rd. UBS Group lifted their target price on Surgery Partners from $12.00 to $19.00 and gave the company a “neutral” rating in a research report on Thursday, February 20th. BidaskClub downgraded Surgery Partners from a “buy” rating to a “hold” rating in a research report on Saturday, February 15th. Citigroup lifted their target price on Surgery Partners from $13.00 to $20.00 and gave the company a “buy” rating in a research report on Tuesday, December 10th. Finally, Benchmark lifted their target price on Surgery Partners from $13.00 to $19.00 and gave the company a “buy” rating in a research report on Tuesday, January 14th. Five analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Surgery Partners presently has a consensus rating of “Hold” and a consensus target price of $17.20.

The firm has a market capitalization of $902.48 million, a price-to-earnings ratio of -3.41 and a beta of 2.68. The company has a quick ratio of 1.24, a current ratio of 1.36 and a debt-to-equity ratio of 2.39. The stock has a 50-day moving average price of $17.69 and a 200 day moving average price of $11.93.

Institutional investors have recently made changes to their positions in the company. Royal Bank of Canada lifted its stake in Surgery Partners by 64.3% during the second quarter. Royal Bank of Canada now owns 5,750 shares of the company’s stock worth $47,000 after purchasing an additional 2,250 shares during the last quarter. Bank of Montreal Can lifted its stake in Surgery Partners by 32.4% during the fourth quarter. Bank of Montreal Can now owns 3,865 shares of the company’s stock worth $61,000 after purchasing an additional 946 shares during the last quarter. Barclays PLC lifted its stake in Surgery Partners by 21.6% during the third quarter. Barclays PLC now owns 19,294 shares of the company’s stock worth $143,000 after purchasing an additional 3,432 shares during the last quarter. Campbell & CO Investment Adviser LLC purchased a new stake in Surgery Partners during the fourth quarter worth approximately $163,000. Finally, SlateStone Wealth LLC purchased a new stake in Surgery Partners during the fourth quarter worth approximately $235,000. 91.07% of the stock is owned by institutional investors and hedge funds.

About Surgery Partners (NASDAQ:SGRY)

Surgery Partners, Inc, through its subsidiaries, owns and operates a network of surgical facilities and related services in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.

Recommended Story: Treasury Bonds

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.